Seasonal influenza vaccination in patients with COPD: a systematic literature review

被引:0
作者
Rafik Bekkat-Berkani
Tom Wilkinson
Philippe Buchy
Gael Dos Santos
Dimitris Stefanidis
Jeanne-Marie Devaster
Nadia Meyer
机构
[1] GSK,Clinical and Experimental Sciences, Faculty of Medicine
[2] University of Southampton,undefined
[3] GSK,undefined
[4] Business & Decision Life Sciences,undefined
[5] GSK,undefined
[6] Present address: GSK,undefined
[7] Present address: Boehringer-Ingelheim Pharma GmbH & Co. KG,undefined
[8] Present address: GSK,undefined
来源
BMC Pulmonary Medicine | / 17卷
关键词
Influenza; Vaccination; COPD; Immunogenicity; Efficacy; Effectiveness; Systematic review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 239 条
[1]  
Adeloye D(2015)Global and regional estimates of COPD prevalence: systematic review and meta-analysis J Glob Health 5 020415-171
[2]  
Chua S(2015)Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013 Lancet 385 117-532
[3]  
Lee C(2006)Global burden of COPD: systematic review and meta-analysis Eur Respir J 28 523-23
[4]  
Basquill C(2016)The global economic burden of asthma and chronic obstructive pulmonary disease Int J Tuberc Lung Dis 20 11-283
[5]  
Papana A(2015)Role of infection in exacerbations of chronic obstructive pulmonary disease Curr Opin Pulm Med 21 278-542
[6]  
Theodoratou E(2010)Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review Respirology 15 536-1203
[7]  
Nair H(2007)Impact of influenza vaccination on major cause-specific mortality Vaccine 25 1196-403
[8]  
Gasevic D(1999)Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease Ann Intern Med 130 397-95
[9]  
Sridhar D(2016)Prevalence of influenza vaccination in chronic obstructive pulmonary disease patients and impact on the risk of severe exacerbations Arch Bronconeumol 52 88-214
[10]  
Campbell H(2016)Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines Expert Rev Vaccines 15 201-1998